TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
TLSA

Tiziana Life Sciences Ltd

Healthcare · Biotechnology

0.9537$ -2.7% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Tiziana Life Sciences Ltd (TLSA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TLSA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-2.3 -5.7 -5.6 -5.7 -4.6 -5.3 -8.8 -16 -16 -12 -1.2 -13
0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2
0.5 4.8 1.3 0.7 0.8 1.3 5.1 5.2 -1.4 1.7 1.4 1.1
1.1 3.2 1.1 -1.3 1.4 2.0 15 2.3 -3.1 – – –
0.2 -0.1 1.0 1.8 1.9 0.2 -0.2 -0.6 -0.9 -1.3 -0.4 3.1
0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.1 -0.3 -0.3 0.0 0.0 0.0 -0.1 0.1 -3.3 -1.0 -0.1 3.0
0.0 0.0 0.0 0.0 0.0 – – – – – – –
7.6 2.6 0.5 1.2 8.6 1.5 – – – – – –
14 10 0.7 1.7 1.7 1.7 -0.1 -0.2 -0.1 -0.1 -0.1 -0.2
4.6 13 1.3 1.2 10 1.3 54 0.0 0.0 0.0 3.6 10
2.1 6.5 -6.0 -4.3 5.2 -4.0 48 -18 -20 -13 2.0 0.3
-2.3 -5.7 -5.7 -5.7 -4.6 -5.3 -8.8 -16 -16 -12 -1.2 -13

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?